| Filed On | Filing |
|---|---|
| 19 Oct 2026 |
8-K: Other Events
IRVINE, Calif., October 19, 2026 – SpyGlass Pharma, Inc. (Nasdaq: SGP) (“SpyGlass Pharma” or “Company”), a late-stage biopharmaceutical company dedicated to transforming the treatment paradigm for patients living with chronic eye conditi... |
| 01 Oct 2026 |
8-K: Regulation FD Disclosure; Other Events
SpyGlass Pharma Acquires Advanced Vision Science, Inc. (AVS), Securing Scalable Commercial IOL Supply and Accelerating Lens Portfolio Expansion Capability |
| 06 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 14 May 2026 | 8-K: Results of Operations and Financial Condition |
| 26 Mar 2026 | 8-K: Results of Operations and Financial Condition |
| 09 Mar 2026 | 8-K: Other Events |
| 13 Feb 2026 | 8-K: Departure/Election of Directors or Officers; Compensation |
| 09 Feb 2026 | 8-K: Departure/Election of Directors or Officers; Compensation; Amendments to Articles/Bylaws; Change in Fiscal Year +1 more |
Loading...
